Acorn Bioventures, L.P. - Insider Trading & Ownership

Location
295 Madison Avenue, 32 Nd Fl, New York, NY
Summary
The estimated value of insider holdings of Acorn Bioventures, L.P. is at least $9.1M dollars as of May 19, 2025. Acorn Bioventures, L.P. is the 10%+ Owner of OnKure Therapeutics, Inc. and owns shares of OnKure Therapeutics, Inc. (OKUR) stock worth about $9.1M.
Signature
ACORN BIOVENTURES, L.P., By: Acorn Capital Advisors GP, LLC, its general partner, By: /s/ Anders Hove, Manager
All Insider Reports
All Insider Reports

Notify me when Acorn Bioventures, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Acorn Bioventures, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
OKUR OnKure Therapeutics, Inc. 10%+ Owner $9.1M +$2.59M +39.8% May 15, 2025

Insider Transactions Reported by Acorn Bioventures, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.